2-(5-(1-((tert-Butoxycarbonyl)amino)ethyl)-1H-1,2,4-triazol-3-yl)acetic acid

Catalog No. :
ACIPRV222
CAS No. :
938459-15-5
Molecular Formula :
C11H18N4O4
Molecular Weight :
270.29

IUPAC Name:2-(3-(1-((tert-butoxycarbonyl)amino)ethyl)-1H-1,2,4-triazol-5-yl)acetic acid

2-(5-(1-((tert-Butoxycarbonyl)amino)ethyl)-1H-1,2,4-triazol-3-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$174.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(5-(1-((tert-Butoxycarbonyl)amino)ethyl)-1H-1,2,4-triazol-3-yl)acetic acid
IUPAC Name2-(3-(1-((tert-butoxycarbonyl)amino)ethyl)-1H-1,2,4-triazol-5-yl)acetic acid
MDL No.MFCD20502953
Molecular FormulaC11H18N4O4
Molecular Weight270.29
SMILESO=C(O)CC1=NNC(C(NC(OC(C)(C)C)=O)C)=N1
InChI KeyFADRJUMYOZQSFZ-UHFFFAOYSA-N
Synonym(5-(1-[(TERT-BUTOXYCARBONYL)AMINO]ETHYL)-4H-1,2,4-TRIAZOL-3-YL)ACETIC ACID;(5-{1-[(tert-butoxycarbonyl)amino]ethyl}-4H-1,2,4-triazol-3-yl)acetic acid(SALTDATA: FREE);1H-1,2,4-Triazole-3-acetic acid, 5-[1-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-;2-(5-(1-((tert-Butoxycarbonyl)amino)ethyl)-1H-1,2,4-triazol-3-yl)acetic acid
CAS No.938459-15-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACIPRV222 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIPRV222 route product structure diagram
    ACIPRV222938459-15-5
Inquiry

2. ACIPRV222 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIPRV222 route product structure diagram
    ACIPRV222938459-15-5
Inquiry

Comments (0)